Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya.
- 1 September 2000
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 6 (9) , 951-955
- https://doi.org/10.1038/79626
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Pre-clinical development of a multi-CTL epitope-based DNA prime MVA boost vaccine for AIDSImmunology Letters, 1999
- Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi.Journal of Clinical Investigation, 1998
- Four novel cytotoxic T-lymphocyte epitopes in the highly conserved major homology region of HIV-1 Gag, restricted through B*4402, B*1801, A*2601, B*70 (B*1509)AIDS, 1998
- Antigen–specific release of β-chemokines by anti-HIV-1 cytotoxic T lymphocytesCurrent Biology, 1998
- Induction of Bystander T Cell Proliferation by Viruses and Type I Interferon in VivoScience, 1996
- Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaquesNature Medicine, 1995
- ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids.Journal of Clinical Investigation, 1995
- HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian womenNature Medicine, 1995
- Induction of CD8+ cytotoxic T lymphocytes by immunization with syngeneic irradiated HIV-1 envelope derived peptide-pulsed dendritic cellsInternational Immunology, 1993
- HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infantThe Lancet, 1993